Press release
Endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders & infertility.
Get a sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/306?utm_source=openpr&utm_medium=Niranjan
The tests detect the imbalance in hormonal levels. The various tests, their advantages, and uses are described in the report. The endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders, infertility, etc. This has also resulted in the development of new technologies, which is driving the growth of this market. High development costs required for developing new technologies could impede the growth of this market. The opportunities for this market are tremendous as rising incidences of endocrine disorders and increasing health care awareness would require rapid, sensitive and low priced tests.
Endocrine Testing Market by Test:
The endocrine tests are used to test the levels of Follicle stimulating hormone(FSH), Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone(TSH), Dehydroepiandrosterone sulfate (DHEAS), Prolactin, Progesterone, Insulin, Cortisol, Testosterone, Estradiol(E2), Luteinizing Hormone (LH) and others. The incidence of diabetes is increasing worldwide. This would require testing of insulin levels. Also, the cases of thyroid disorders are increasing which would further increase the demand for the tests.
Endocrine Testing Market by Diagnostic Technology:
The endocrine tests are Immunoassay, Clinical Chemistry tests, tests utilizing Monoclonal and Polyclonal Antibody, and Tandem Mass Spectroscopy. Mass spectroscopy analysis is the most recent technology available. The sensitivity of the tests using mass spectroscopy is very high.
Purchase the report @ Discount: https://www.alliedmarketresearch.com/checkout/80830?utm_source=openpr&utm_medium=Niranjan
Endocrine Testing Market by an end user:
The endocrine tests are used in Hospitals, Physicians Offices, Health Care centers, Commercial Laboratories, etc. Hospitals are the major users for these tests with a large number of people visiting hospitals for testing.
Endocrine Testing Market by Geography:
The endocrine testing market is segmented into North America, Europe, Asia Pacific, and RoW. The market is dominated by North America followed by Europe, as there is greater awareness in these regions. However, the market in Asia-Pacific is expected to grow as the incidences of endocrine disorders are rising in these regions.
Competitive Analysis:
The key players in this market are Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho-Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories, and others. In May 2012, Quest Diagnostics announced four new tests panels for congenital adrenal hyperplasis (CAH), an endocrine disorder. The tests promise to provide a faster and high-quality diagnosis of CAH.
High-Level Analysis:
According to Porter’s five force model, the bargaining power of the buyer is high in this market, as there is a wide range of test kits manufactured by many companies. The threat posed by new entrants is also analyzed. The key drivers, restraints, and opportunities are described to help in better understanding the market. Business strategies implemented by competitors are analyzed. The value chain analysis of the endocrine testing market is strategically dealt with in the report.
Key Benefits:
• Market segmentation by technology helps in understanding the current technologies as well as future developments on this front.
• In-depth analysis of tests used would help in the identification of future applications.
• Market estimates for the period of 2012-2020 are given, which would give a clear idea of current and future prospects for the market.
• Key factors influencing the market are given which would enable a better understanding of the growth of this market.
• Geographic segmentation would help in identifying untapped regions where expansion could be possible.
Key Deliverables
The endocrine testing market is segmented by test, diagnostic technology, end user and geography.
Market by Test:
• Follicle stimulating hormone(FSH)
• Human Chorionic Gonadotropin (hCG)
• Thyroid Stimulating Hormone(TSH)
• Dehydroepiandrosterone sulfate (DHEAS)
• Prolactin
• Progesterone
• Insulin
• Cortisol
• Testosterone
• Estradiol(E2)
• Luteinizing Hormone (LH)
Market by Diagnostic Technology:
• Immunoassay
• Clinical Chemistry
• Monoclonal and Polyclonal Antibody
• Tandem Mass Spectroscopy
Market by End User:
• Hospitals
• Physicians Offices
• Health Care Centers
• Commercial Laboratories
Market by Geography:
• North America
• Europe
• Asia Pacific
• RoW
About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders & infertility. here
News-ID: 1526718 • Views: …
More Releases from Allied Market Research
Herbal Die tary Supplement Market Size, Industry Analysis, Growth Drivers, Oppor …
The herbal die tary supplement market size was valued at $11 billion in 2022, and is estimated to reach $21.4 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.
Herbal die tary supplements are natural items made from plants or plant extracts that are taken to supplement the diet and improve health and well-being. These supplements frequently contain a combination of vitamins, minerals, amino acids, and other…
Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion …
Allied Market Research published a new report, titled, "Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
MarTech Market Witnessing CAGR of 18.5% Hit USD 1.7 Trillion by 2032
The global marketing technology market is experiencing growth due to several factors, including the increasing digital transformation, the surge in demand for personalized experience, and the proliferation of automation and efficiency. However, data privacy and compliance, and the high cost of implementation are expected to hamper market growth. Furthermore, the growing integration of AI and ML technologies and the increase in demand for real-time marketing are anticipated to provide lucrative…
Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Bi …
Allied Market Research published a new report, titled, "Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Billion by 2031 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and…
More Releases for Endocrine
Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endocrine Testing Industry Market Size Be by 2025?
In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth…
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period?
The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to…
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market?
The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40…
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market?
The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government…
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market?
In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones…
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is…
